Skip to main
TELO
TELO logo

TELO Market Capitalization Overview

Market Cap: $58.34M as of Jun 13, 2025

$58.34M
Past Month-$11.91M (16.95%)
As of Jun 13, 2025, TELO has a market capitalization of $58.34M. Over the past 30 days, its market cap has decreased by -16.33%, while in the last 12 months, it has decreased by -52.41%.

Market capitalization represents the total value of Telomir Pharmaceuticals Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

TELO Market Cap Formula = Stock Price * Shares Outstanding

The market cap of TELO helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

TELO Market Cap History

DateMarket CapChange
Jun 2, 2025$62.51M-16.33%
May 1, 2025$74.71M-8.39%
Apr 1, 2025$81.55M-33.33%
Mar 3, 2025$122.33M-1.41%
Feb 3, 2025$124.07M+2.46%
Jan 2, 2025$121.10M-3.77%

TELO End of Year Market Cap History

DateMarket CapChange
2025$58.34M-52.41%
2024$122.59M

FAQs About Telomir Pharmaceuticals Inc (TELO) Market Cap

As of Jun 13, 2025, the market capitalization of TELO is $58.34M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Telomir Pharmaceuticals Inc’s market capitalization has decreased by -16.95%, changing from $70.24M to $58.34M as of Jun 13, 2025.

In the last 3 months, Telomir Pharmaceuticals Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Telomir Pharmaceuticals Inc’s market capitalization increased from – in January to $122.59M in December, reflecting a — change.

Telomir Pharmaceuticals Inc (TELO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.